Kesang Li
- Molecular Biology
- Oncology top 10%
- Cancer Research top 10%
- Immunology top 10%
- Hepatology top 10%
- Topics
- CAR-T cell therapy research (5 papers)Circular RNAs in diseases (4 papers)RNA modifications and cancer (3 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Kesang Li
19 papers receiving 801 citations
Peers
Comparison fields: 5 of 54
- Molecular Biology 428
- Oncology 364
- Cancer Research 274
- Immunology 270
- Hepatology 99
Countries citing papers authored by Kesang Li
This map shows the geographic impact of Kesang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kesang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kesang Li more than expected).
Fields of papers citing papers by Kesang Li
This network shows the impact of papers produced by Kesang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kesang Li. The network helps show where Kesang Li may publish in the future.
Co-authorship network of co-authors of Kesang Li
This figure shows the co-authorship network connecting the top 25 collaborators of Kesang Li. A scholar is included among the top collaborators of Kesang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kesang Li. Kesang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 24 | |
| 3 | 3 | |
| 4 | Development of GPC3 and EGFR-dual-targeting chimeric antigen receptor-T cells for adoptive T cell therapy. | 13 |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 20 | |
| 8 | 15 | |
| 9 | 38 | |
| 10 | 192 | |
| 11 | 36 | |
| 12 | 12 | |
| 13 | 82 | |
| 14 | 2 | |
| 15 | 13 | |
| 16 | 6 | |
| 17 | 32 | |
| 18 | 259 | |
| 19 | 20 | |
| 20 | 39 |
About Kesang Li
Kesang Li is a scholar working on Oncology, Immunology and Cancer Research, having authored 20 papers that have together received 811 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Circular RNAs in diseases (4 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (274 citations), Oncology (364 citations) and Immunology (270 citations). Kesang Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiaorong Pan, Zonghai Li, Hua Jiang, Bizhi Shi, Huiping Gao, Hongyang Wang, Pengfei Zhang, Jing Wu, Shengli Yang and Jianren Gu. Their work appears in journals such as Cancer Research, Clinical Cancer Research and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.